Ausgabe 3/2018
Inhalt (11 Artikel)
Meta-analysis of randomized clinical trials in the era of individual patient data sharing
Takuya Kawahara, Musashi Fukuda, Koji Oba, Junichi Sakamoto, Marc Buyse
Incidence, risk and prognostic role of anti-epidermal growth factor receptor-induced skin rash in biliary cancer: a meta-analysis
Fangqiang Wei, Donghun Shin, Xiujun Cai
Feasibility and effectiveness of trifluridine/tipiracil in metastatic colorectal cancer: real-life data from The Netherlands
Johannes J. M. Kwakman, G. Vink, J. H. Vestjens, L. V. Beerepoot, J. W. de Groot, R. L. Jansen, F. L. Opdam, H. Boot, G. J. Creemers, J. M. van Rooijen, M. Los, A. J. E. Vulink, H. Schut, E. van Meerten, A. Baars, P. Hamberg, E. Kapiteijn, D. W. Sommeijer, C. J. A. Punt, M. Koopman
Phase I study of primary treatment with 5-FU, oxaliplatin, irinotecan, levofolinate, and panitumumab combination chemotherapy in patients with advanced/recurrent colorectal cancer involving the wild-type RAS gene: the JACCRO CC-14 study
Hironaga Satake, Akihito Tsuji, Masato Nakamura, Masaaki Ogawa, Takeshi Kotake, Yukimasa Hatachi, Hisateru Yasui, Akinori Takagane, Yoshihiro Okita, Kumi Nakamura, Toshihide Onikubo, Masahiro Takeuchi, Masashi Fujii
Differences in histological features and PD-L1 expression between sporadic microsatellite instability and Lynch-syndrome-associated disease in Japanese patients with colorectal cancer
Rin Yamada, Tatsuro Yamaguchi, Takeru Iijima, Rika Wakaume, Misato Takao, Koichi Koizumi, Tsunekazu Hishima, Shin-ichiro Horiguchi
A comparison of the prognosis between adenocarcinoma and squamous cell carcinoma in stage IB–IIA cervical cancer
Xiuzhen Xie, Kun Song, Baoxia Cui, Jie Jiang, Xingsheng Yang, Beihua Kong
Lymphatic vessel involvement is predictive for lymph node metastasis and an important prognostic factor in endometrial cancer
Akihiko Wakayama, Wataru Kudaka, Hirofumi Matsumoto, Hajime Aoyama, Takuma Ooyama, Yusuke Taira, Yoshihisa Arakaki, Yuko Shimoji, Tadaharu Nakasone, Kumiko Nishihira, Itomi Kaneshima, Tomoko Tamaki, Naoki Yoshimi, Yoichi Aoki
Prognostic value of the Glasgow Prognostic Score for patients with metastatic renal cell carcinoma treated by cytoreductive nephrectomy
Hironori Fukuda, Toshio Takagi, Tsunenori Kondo, Kazuhiko Yoshida, Satoru Shimizu, Yoji Nagashima, Kazunari Tanabe
Oncological outcomes after cytoreductive nephrectomy for patients with metastatic renal cell carcinoma with inferior vena caval tumor thrombus
Hideaki Miyake, Takayuki Sugiyama, Ryota Aki, Yuto Matsushita, Keita Tamura, Daisuke Motoyama, Toshiki Ito, Atsushi Otsuka
Efficacy and safety of third-line molecular-targeted therapy in metastatic renal cell carcinoma resistant to first-line vascular endothelial growth factor receptor tyrosine kinase inhibitor and second-line therapy
Hiroki Ishihara, Toshio Takagi, Tsunenori Kondo, Hidekazu Tachibana, Kazuhiko Yoshida, Kenji Omae, Junpei Iizuka, Hirohito Kobayashi, Kazunari Tanabe